GlassScriptPhysician profile
Ramkishen Narayanan
NPI 1215296348
$15,326.43
in general payments reported to CMS, 2019-2025
40 companies · $9,283 in 2025
The $9,283 reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $152 · 2021: $1,011 · 2022: $354 · 2023: $935 · 2024: $3,028 · 2025: $9,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Food and Beverage: $3,775 · Travel and Lodging: $1,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Food and Beverage | $3,775.23 |
| Travel and Lodging | $1,970.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,898.79 | 2021-2025 | Da Vinci Surgical System |
| Teleflex LLC | $628.66 | 2021-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $448.10 | 2023-2025 | Lithovue, Spaceoar System, Lithoclast |
| Urogen Pharma, INC. | $353.46 | 2023 | Jelmyto |
| Astellas Pharma US INC | $283.88 | 2021-2025 | Xtandi |
| Osiris Therapeutics INC. | $279.90 | 2019 | |
| Ferring Pharmaceuticals INC. | $162.20 | 2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $157.04 | 2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $156.98 | 2025 | |
| Dendreon Pharmaceuticals LLC | $149.00 | 2019 | |
| Procept Biorobotics Corporation | $141.25 | 2023 | Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $140.08 | 2025 | |
| Biotissue Holdings INC. | $139.16 | 2019-2024 | |
| Baxter Healthcare | $126.31 | 2024-2025 | Tisseel |
| Laborie Medical Technologies Corp. | $124.81 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $119.05 | 2020 | |
| Smith+Nephew, INC. | $96.04 | 2019-2024 | Stravix |
| Ambu INC. | $93.70 | 2023 | |
| Progenics Pharmaceuticals, INC. | $82.30 | 2025 | |
| Janssen Biotech, INC. | $68.90 | 2023-2025 | Erleada |
| Pfizer INC. | $61.55 | 2023-2025 | |
| C. R. Bard, INC. & Subsidiaries | $52.19 | 2023-2025 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $51.82 | 2022 | |
| Merck Sharp & Dohme LLC | $48.80 | 2022-2023 | Keytruda |
| Antares Pharma, INC. | $48.57 | 2025 | Xyosted |
| Immunitybio, INC. | $46.73 | 2025 | |
| Angiodynamics, INC. | $45.21 | 2025 | Nanoknife |
| Ceribell, INC. | $38.81 | 2025 | Pocket Eeg Device |
| Myriad Genetic Laboratories, INC. | $34.96 | 2022-2025 | Prolaris |
| Neotract INC. | $33.01 | 2020 | |
| 180 Medical, INC. | $29.58 | 2025 | |
| Civco Medical Instruments | $25.21 | 2025 | |
| Novo Nordisk INC | $23.77 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $23.65 | 2023 | Tagrisso |
| Bioprotect Medical, INC. | $22.10 | 2025 | Bioprotect Balloon Implant System |
| Neurelis, INC. | $20.42 | 2022 | |
| Endo Pharmaceuticals INC. | $19.92 | 2022 | |
| Myovant Sciences INC. | $19.16 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.27 | 2022 | |
| Calyxo, INC. | $15.09 | 2025 | Cvac Aspiration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramkishen Narayanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.